Creative Biolabs is helping researchers overcome challenges of gene therapy research by providing analytical testing ...
Cell and gene therapies rely on engineered viruses to deliver them to their cellular destinations. While the progress of these types of medicines is evident in a growing number of FDA product ...
Whether it’s vaccines, protein production, or biotherapeutics, lentiviral vectors are increasingly being recognized for their central role as an enabling technology. The ability of lentiviral vectors ...
A new vector system known as lentiviral vectors can permanently integrate the gene into dividing and non-dividing cells. The capacity of lentiviral vectors to reliably integrate at various genomic ...
Discover how platformed lentiviral manufacturing and ready-to-deploy CAR-T solutions are breaking the critical barriers of ...
Lentiviral vectors are important gene delivery tools for cell and gene therapies, notably chimeric antigen receptor T-cell (CAR-T cell) therapies which have proven successful in treating a growing ...
Vector BioMed raised $15 million in a first round of funding as the startup looks to help fill a big gap in the manufacture of cell and gene therapies. The latest entry into the CDMO viral vector ...
GERMANTOWN, Md. and PRAGUE, Czech Republic, May 18, 2023 (GLOBE NEWSWIRE) -- (NASDAQ: ORGS) (“Orgenesis”), a global biotech company working to unlock the full potential of cell and gene therapies (CGT ...
After years of delays and setbacks, the lentiviral vector gene therapy platform has secured two FDA approvals. The agency approved bluebird bio’s betibeglogene autotemcel for severe β-thalassemia in ...
This story is part of a series on the current progression in Regenerative Medicine. In 1999, I defined regenerative medicine as the collection of interventions that restore tissues and organs damaged ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results